Fab'entech   Report issue

For profit Phase 1 Phase 2
Founded: Lyon France (2009)
Status: Left NME R&D (2017)

Organization Overview

First Clinical Trial
2012
NCT02295813
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Fab'entech